- Home
- ELAN vs OWL Comparison
ELAN vs OWL Comparison
Compare ELAN & OWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ELAN | OWL |
|---|---|---|
| Founded | 1954 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.3B | 9.4B |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | ELAN | OWL |
|---|---|---|
| Price | $24.91 | $15.65 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 15 |
| Target Price | ★ $24.44 | $21.70 |
| AVG Volume (30 Days) | 4.6M | ★ 10.4M |
| Earning Date | 02-24-2026 | 02-05-2026 |
| Dividend Yield | N/A | ★ 5.71% |
| EPS Growth | N/A | ★ 47.85 |
| EPS | 0.07 | ★ 0.08 |
| Revenue | ★ $4,591,000,000.00 | $2,745,943,000.00 |
| Revenue This Year | $7.25 | $18.19 |
| Revenue Next Year | $5.69 | $19.13 |
| P/E Ratio | $343.18 | ★ $203.26 |
| Revenue Growth | 3.08 | ★ 27.24 |
| 52 Week Low | $8.02 | $13.25 |
| 52 Week High | $24.98 | $26.73 |
Technical Indicators
Market Signals| Indicator | ELAN | OWL |
|---|---|---|
| Relative Strength Index (RSI) | 66.71 | 51.28 |
| Support Level | $23.67 | $15.27 |
| Resistance Level | $24.98 | $16.11 |
| Average True Range (ATR) | 0.81 | 0.56 |
| MACD | 0.10 | 0.01 |
| Stochastic Oscillator | 89.06 | 60.09 |
Price Performance
Historical ComparisonAbout ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.
About OWL Blue Owl Capital Inc.
Blue Owl Capital is one of the world's largest alternative-asset managers, $295.6 billion in total managed assets, including $183.8 billion in fee-earning AUM, at the end of September 2025. The company has three core business segments: global private equity, (with $68.8 billion in total AUM and $40.2 billion in fee-earning AUM), private credit ($152.1 billion/$97.3 billion), and real estate/real assets ($74.7 billion/$46.3 billion). The firm primarily serves institutional investors (68% of AUM) and high-net-worth individuals (32%). The firm operates through more than 20 offices in the Americas, and the EMEA and Asia-Pacific regions.